The Effectiveness and Safety Profile of Nivolumab‐Plus‐Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J‐ <scp>ENCORE</scp> Study)

Authors

Institutions

Publication Details

Journal
International Journal of Urology
Published
2025-04-24
DOI
https://doi.org/10.1111/iju.70076
Citations
4
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
6.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effectiveness and Safety Profile of Nivolumab‐Plus‐Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J‐ ENCORE Study)

Kazuyuki Numakura, Tomokazu Sazuka, Sei Naito, Atsushi Mizokami et al.
4 citations
International Journal of Urology
Renal cell carcinoma treatment
6.07
article

The Effectiveness and Safety Profile of Nivolumab‐Plus‐Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J‐ ENCORE Study)

Kazuyuki Numakura, Tomokazu Sazuka, Sei Naito, Atsushi Mizokami, Go Kimura, Hiroaki Ito, Masayoshi Nagata, Hirotsugu Uemura, Kojiro Ohba, Takashige Abe, Shuzo Hamamoto, Koshiro Nishimoto, Masahiro Nozawa, Tsunenori Kondo, Shinsaku ONODERA
article en
4 citations

Abstract

No abstract available for this paper.
International Journal of UrologyVol. 32(8)
Kanazawa University (JP), Yamagata University (JP), Chiba University (JP), Akita University (JP), Hokkaido University (JP), Nagoya City University (JP), Juntendo University (JP), Ono Pharmaceutical (Japan) (JP), Tokyo Women's Medical University Adachi Medical Center (JP), Bristol-Myers Squibb (Japan) (JP), Nippon Medical School Hospital (JP), Nagasaki University (JP), Saitama Medical University (JP), Kindai University (JP)
Bristol-Myers Squibb, Japanese Urological Association, Ono Pharmaceutical
Good health and well-being
Openalex Percentile: Top 4%
Renal cell carcinoma treatment
6.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Effectiveness and Safety Profile of Nivolumab‐Plus‐Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J‐ <scp>ENCORE</scp> Study) — Kazuyuki Numakura, Tomokazu Sazuka, et al. · International Journal of Urology (2025) | TGRS Research Map | TGRS